Dementia News and Research

Latest Dementia News and Research

Twin brains reveal similar progressions of neuropathological changes

Despite widespread use of a single term, Alzheimer's disease is actually a diverse collection of diseases, symptoms and pathological changes.

3 Mar 2014

Study investigates associations between self-rated physical fitness and dementia risk

How would you rate your own physical fitness? Is it good, satisfactory or maybe even poor? Surprisingly, your answer may reveal your future risk of getting dementia.

26 Feb 2014

Music in health care can improve quality of life for older people

Using music and singing in health care can improve quality of life for older people by easing pain, anxiety and depression.

26 Feb 2014

Increased brain cell activity boosts protein linked to Alzheimer's disease

Increased brain cell activity boosts brain fluid levels of a protein linked to Alzheimer's disease, according to new research from scientists at Washington University School of Medicine in St. Louis.

26 Feb 2014

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke.

25 Feb 2014

Jackson Laboratory Assistant Professor wins 2013 Lewis Rudin Glaucoma Prize from NYAM

Jackson Laboratory Assistant Professor Gareth Howell, Ph.D., is one of two winners of the 2013 Lewis Rudin Glaucoma Prize from The New York Academy of Medicine.

24 Feb 2014

Nurses can increase quality of life in older patients by promoting exercise

Nurses can increase independence and quality of life as well as reduce social isolation in older patients by promoting exercise.

24 Feb 2014

Omega-3 supplements, sertraline could help prevent onset of depression and dementia in later life

A University of Sydney study is looking into the effectiveness of omega-3 supplements and the antidepressant, sertraline, in reducing depressive symptoms and cognitive decline in older people, in a bid to prevent the onset of depression and dementia in later life.

24 Feb 2014

Study links carbohydrate calorie-rich diets to greater risk for brain shrinkage, dementia and AD

Even small increases in blood sugar caused by a diet high in carbohydrates can be detrimental to brain health. Recent reports in medical literature link carbohydrate calorie-rich diets to a greater risk for brain shrinkage, dementia and Alzheimer's disease, impaired cognition, and other disorders.

24 Feb 2014

Motivation to do preventative exercise may reduce risk of fall in older adults

Every year, a third of people over 65 living in the UK will experience a fall.

21 Feb 2014

CEOi, New York Academy to launch Global Alzheimer's Platform to reduce time, costs of clinical trials

The Global CEO Initiative (CEOi) on Alzheimer's Disease and the New York Academy of Sciences today convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer's Platform (GAP), designed to reduce the time and costs of Alzheimer's clinical trials, develop an infrastructure that promotes innovation, and assure international collaboration.

21 Feb 2014

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

An antidepressant medication has shown potential in treating symptoms of agitation that occur with Alzheimer's disease and in alleviating caregivers' stress, according to a multi-site U.S.- Canada study.

20 Feb 2014

Researchers examine impact of diet for preventing Alzheimer's dementia

A cocktail of ingredients containing omega-3 fatty acid found in fish oil is being tested in patients with mild cognitive impairment as a means to slow the progression of Alzheimer's dementia down

19 Feb 2014

Highlights: Ohio gov.'s evolving stances; Conn. social services woes; abortion-ban push continues

A selection of health policy stories from Ohio, Connecticut, South Carolina, Mississippi, Florida, California, New York, Oklahoma, Washington, Massachusetts, North Carolina, Texas, Virginia and Georgia.

19 Feb 2014

Neuropsychological assessment efficiently tracks disease progression in memory clinic patients

Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing. MRI measures of brain atrophy were shown to be less reliable to pick up changes in the same patients.

19 Feb 2014

Researchers are unraveling the mysteries of amyloid beta peptides in Alzheimer's disease

Alzheimer's disease has long been marked by progress -- but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age; for those living with the disease, its ravages get worse over time; and as we move into the 21st century, it will place a greater and greater burden on society.

18 Feb 2014

Blood pressure effects unclear in long-term stroke survivors

Long-term survivors of stroke whose blood pressure is at target levels have worse outcomes than those with slightly elevated levels, research suggests.

17 Feb 2014

Highlights: N.D. hospital and abortion docs; Calif. sugary beverage bill; aging home care workers in Texas

A Democratic candidate who has explicitly defended Obamacare holds a slight lead in a special congressional election in Florida that both parties are eyeing as a test of the political impact of the healthcare law. A poll released Thursday by the Tampa Bay Times shows Democrat Alex Sink leading her Republican opponent, David Jolly, 42% to 35% among people considered likely to vote in the March 11 special election.

17 Feb 2014

Resolution of inflammation is altered in Alzheimer's disease

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease.

17 Feb 2014

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

16 Feb 2014

Dementia News and Research

Latest Dementia News and Research

Twin brains reveal similar progressions of neuropathological changes

Study investigates associations between self-rated physical fitness and dementia risk

Music in health care can improve quality of life for older people

Increased brain cell activity boosts protein linked to Alzheimer's disease

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

Jackson Laboratory Assistant Professor wins 2013 Lewis Rudin Glaucoma Prize from NYAM

Nurses can increase quality of life in older patients by promoting exercise

Omega-3 supplements, sertraline could help prevent onset of depression and dementia in later life

Study links carbohydrate calorie-rich diets to greater risk for brain shrinkage, dementia and AD

Motivation to do preventative exercise may reduce risk of fall in older adults

CEOi, New York Academy to launch Global Alzheimer's Platform to reduce time, costs of clinical trials

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

Researchers examine impact of diet for preventing Alzheimer's dementia

Highlights: Ohio gov.'s evolving stances; Conn. social services woes; abortion-ban push continues

Neuropsychological assessment efficiently tracks disease progression in memory clinic patients

Researchers are unraveling the mysteries of amyloid beta peptides in Alzheimer's disease

Blood pressure effects unclear in long-term stroke survivors

Highlights: N.D. hospital and abortion docs; Calif. sugary beverage bill; aging home care workers in Texas

Resolution of inflammation is altered in Alzheimer's disease

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Dementia News and Research

Latest Dementia News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in